the dietary supplements information expert committee dsiec of the united states pharmacopeial convention usp reviews the safety of dietary supplements and dietary supplement ingredients for the purpose of determining whether they should be admitted as quality monographs into the united states pharmacopeia and national formulary uspnfthe united states food and drug administration fda has enforcement authority to pursue a misbranding action in those instances where a dietary supplement product indicates that it conforms to usp standards but fails to so conformrecently dsiec undertook a safety evaluation of spirulina a widely used dietary ingredientdsiec reviewed information from human clinical trials animal studies and regulatory and pharmacopeial sources and analyzed 31 adverse event reports regarding spirulina to assess potential health concernsat the conclusion of this review dsiec assigned a class a safety rating for spirulina maxima and s platensis thereby permitting the admission of quality monographs for these dietary supplement ingredients in uspnfdsiec continually monitors reports concerning the safety of dietary supplements and dietary supplement ingredients for which usp dietary supplement monographs are developedthe dsiec may revisit the safety classification of spirulina as new information on this dietary ingredient becomes available